Immunogenic mutations in tumor genomes correlate with increased patient survival
Tuesday, April 29, 2014 - 15:01
in Health & Medicine
Developing immunotherapies for cancer is challenging because of significant variability among tumors and diversity in human immune types. In a new study, researchers examined the largest collection of tumor samples to date to predict patient-specific tumor mutations that may activate the patient's immune system, paving the way for more successful, personalized cancer immunotherapy.